Oppenheimer raised the firm’s price target on Atlassian (TEAM) to $300 from $270 and keeps an Outperform rating on the shares. The firm is bullish on Atlassian entering 2025, reiterating it as a top pick behind multiple catalysts. Oppenheimer sees upside leverage emanating from an evolving enterprise sales motion as Atlassian’s new CRO augments the company’s GTM motion and enhances/expands its sales team; and significant up-sell/cross-sell leverage as product packaging/bundling and new product efforts drive expansion/larger deal sizes. While prudent, the firm sees an easing macro backdrop that can drive stronger seat expansion across Atlassian’s entire base.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEAM:
- Atlassian price target raised to $310 from $265 at Piper Sandler
- Atlassian call volume above normal and directionally bullish
- Atlassian price target raised to $285 from $255 at Canaccord
- Atlassian Announces Changes in Board of Directors
- Atlassian price target raised to $375 from $270 at Wolfe Research